Secondary bacterial or fungal co-infections in COVID-19 patients have received inadequate attention from the public. For most, co-infections pose little to no risk according to reports that an estimated 8% of patients are found to experience this during hospital admission – a relatively low number compared to the global impact of the virus. However, once a patient enters a hospital for care or becomes ventilated while in the ICU, the risk for acquiring and spreading a deadly
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
COVID-19 Molecular Test Shipments Top One Million Per Day
The Advanced Medical Technology Association (AdvaMed) today announced that shipments of COVID-19 molecular diagnostic tests reached one million per day for the week ending July 24, based on the latest data from the association's National Testing Registry.
"This incredible milestone is just the latest example of how the medical technology industry is rising to meet the challenges posed by the COVID-19 pandemic," said Scott Whitaker, AdvaMed president and CEO. "Widespread and widely available
Read More
Fujifilm Sonosite Unveils Next-Gen Point-of-Care Ultrasound System for Frontline Clinicians
What You Should Know:
- FUJIFILM Sonosite, Inc. launches its next-generation point-of-care (POCUS) ultrasound system - designed specifically for the clinicians on the front lines of medicine to treat patients more effectively.
- The
product is expected to commercialize in the US, Australia and New Zealand in
July 2020, and in the UK, Spain, Germany and France this August. Sonosite has
received nearly 600 leads (and counting) from healthcare providers and medical
facilities in the U.S.
Read More
Paige Lands Additional $20M for AI-Native Digital Pathology Ecosystem
What You Should Know:
- Paige secures an additional $15M from Goldman Sachs totaling $20M to close out a total Series B funding round of $70M for its AI-native digital pathology ecosystem.
- The company’s continued product portfolio of innovation in telepathology and digital diagnostics accelerated by further investment.
Paige, an NYC-based leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it received an additional $15M from
Read More
Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics
What You Should Know:
- Repurpose.AI, has partnered with Scripps Research to
discover drug candidates that may be repurposed to treat COVID-19.
- The partnership will leverage Repurpose.AI's ActivPred
AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic
digital chemistry engine, to discover drug candidates to treat COVID-19.
Scripps Research is
teaming up with Repurpose.AI, an AI
drug discovery company to develop COVID-19 therapeutics. The
Read More
New Lighthouse Initiative to Provide De-identified Patient Data for VIRUS COVID-19 Registry
What You Should Know:
- PointClickCare introduces
the Lighthouse initiative, which will provide de‐identified
data on COVID‐19 diagnosed patients, including demographics, vitals,
medications and health‐related outcomes, in order to better understand health
outcomes post‐ICU.
- Comprehensive data sets are especially critical tools
in responding to crises like the current COVID-19 pandemic, and this initiative
is one example of PointClickCare’s efforts to
Read More
Cleveland Clinic Florida Opens Florida Research and Innovation Center
What You Should Know:
- Cleveland Clinic Florida opens Florida Research and
Innovation Center that will advance innovative translational research, focused
on immuno-oncology and infectious diseases, including COVID-19.
- The 107,000-square-foot, state-of-the-art research facility features modern laboratory space, biosafety level 3 facilities for work with infectious agents, and office space for support services on eight acres of land.
Cleveland
Clinic Florida announced
Read More
Propeller Health, Novartis Co-Package Asthma Medication in Europe for Prescription
What You Should Know:
- Propeller Health announced
it will co-package a new asthma medication from Novartis, which was
approved by the European Commission this week for use in the EU.
- Enerzair®
Breezhaler® plus Propeller Health sensor is the first asthma medication to be
co-packaged and co-prescribed with a digital health platform.
- Propeller’s solution
works by attaching a sensor to the Enerzair® Breezhaler® inhaler, which then
delivers objective data on medication use to the
Read More
Eliminating the Long, Cumbersome and Costly Diagnosis of Genetic Diseases
The answer to questions about human disease can be found in our genes. The difficulty in the past has been the testing process, a sort of trial and error approach of drilling down into the multitude of variants that can be found within the genes, variants that when analyzed in tandem with detailed clinical histories can actually tell the story and lead to a faster diagnosis.
Human beings carry around 20,000 genes and, of those, approximately 5,000 are somewhat understood, and those genes can
Read More
Verily, Cognizant Collaborate on Baseline COVID-19 Testing Program
What You Should Know:
- Cognizant has announced its collaboration with Verily
Life Sciences to facilitate and help increase easy and efficient COVID-19
testing across the U.S – which will be critical to ensuring the safety of
individuals going out and back to work as states reopen.
- Through this collaboration, Cognizant is providing a
team of its life sciences experts to support Verily’s Baseline COVID-19 Testing
Program to increase access to individuals needing to schedule COVID-19
Read More
